(3R,4S)-1-[(benzyloxy)carbonyl]-4-ethylpyrrolidine-3-carboxylic acid

1428243-25-7

CAS-Nr.: 1428243-25-7

Englisch Name:: (3R,4S)-1-[(benzyloxy)carbonyl]-4-ethylpyrrolidine-3-carboxylic acid

Synonyma:: Olutasidenib Impurity 27;Upadacitinib Impurity 23;(E/Z)-9-Hydroxy-5,9-dimethyldec-4-enal;benzyl (3S,4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate;(3R,4S)-1-[(benzyloxy)carbonyl]-4-ethylpyrrolidine-3-carboxylic acid;(R)-1-(naphthalen-1-yl)ethanamine (3r,4s)-1-(benzyloxycarbonyl)-4-ethylpyrrolidine-3-carboxylate;(3R,4S)-4-Ethyl-1,3-pyrrolidinedicarboxylic acid 1-(phenylmethyl) ester (alphaR)-alpha-methyl-1-naphthalenemethanamine

CBNumber:: CB53335001

Summenformel:: C15H19NO4

Molgewicht:: 277.31566

MOL-Datei:: 1428243-25-7.mol

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 29

(3R,4S)-1-[(benzyloxy)carbonyl]-4-ethylpyrrolidine-3-carboxylic acid Eigenschaften

Sicherheit

(3R,4S)-1-[(benzyloxy)carbonyl]-4-ethylpyrrolidine-3-carboxylic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

(E/Z)-9-Hydroxy-5,9-dimethyldec-4-enal acts as a reagent in the preparation of imidazopyrrolopyrazine derivatives and analogs for use as protein kinase modulators.

(3R,4S)-1-[(benzyloxy)carbonyl]-4-ethylpyrrolidine-3-carboxylic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester

(3R,4S)-1-[(benzyloxy)carbonyl]-4-ethylpyrrolidine-3-carboxylic acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 29)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Neostar United (Changzhou) Industrial Co., Ltd.	+86-519-519-85557386	marketing1@neostarunited.com	China	12414	58
Hefei TNJ Chemical Industry Co.,Ltd.	0551-65418684 +8618949823763	sales@tnjchem.com	China	25363	58
Nantong HI-FUTURE Biology Co., Ltd.	+undefined18051384581	sales@chemhifuture.com	China	3136	58
SUZHOU SENFEIDA CHEMICAL CO.,LTD	+86-0512-83500002 +8615195660023	sales@senfeida.com	China	10814	58
China National Standard Pharmaceutical Corporation Limited	+8615391658522	overseasales@yongstandards.com	China	11927	58
Changzhou AniKare Pharmatech Co., Ltd.	+86-0519-8359-8696 +8618018249389	sales@anikare.com	China	8559	58
Suzhou ARTK Medchem Co., Ltd.	+8618168183658	sales1@artkmedchem.com	China	39009	58
Apeloa production Co.,Limited	+8619933239880	admin@apcl.com.cn	China	853	58
nanjing dingda Pharmatech. co. ltd	18013843276	1642441764@qq.com	China	93	58
Suli Pharmaceutical Technology Co., Ltd.	021-021-58086325-8012-8012 13636568474	yingjie.zhang@suli.com	China	106	58

(3R,4S)-1-[(benzyloxy)carbonyl]-4-ethylpyrrolidine-3-carboxylic acid
(3R,4S)-4-Ethyl-1,3-pyrrolidinedicarboxylic acid 1-(phenylmethyl) ester (alphaR)-alpha-methyl-1-naphthalenemethanamine
(R)-1-(naphthalen-1-yl)ethanamine (3r,4s)-1-(benzyloxycarbonyl)-4-ethylpyrrolidine-3-carboxylate
benzyl (3S,4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
(E/Z)-9-Hydroxy-5,9-dimethyldec-4-enal
Upadacitinib Impurity 23
Olutasidenib Impurity 27
1428243-25-7